Coronary Artery Disease News and Research

Latest Coronary Artery Disease News and Research

Detection of blood biomarker cTnT associated with structural heart disease

With the use of a highly sensitive test, detection of the blood biomarker cardiac troponin T, a cardiac-specific protein, is associated with structural heart disease and an increased risk of all-cause death, according to a study in the December 8 issue of JAMA.

8 Dec 2010

New sensitive blood test could determine unrecognized heart disease

A more sensitive version of a blood test typically used to confirm that someone is having a heart attack could indicate whether a seemingly healthy, middle-aged person has unrecognized heart disease and an increased risk of dying, UT Southwestern Medical Center researchers have found.

7 Dec 2010

Sheathless transradial intervention highly successful in treating complex lesions

Cardiologists from the Mayo Clinic performed sheathless transradial percutaneous coronary intervention (PCI) to remedy complex lesions, achieving a 90% success rate with no radial complications. Standard guiding catheters were used during the procedure. Details of this novel approach—overcoming the last hurdle to greater adoption of transradial PCI in the U.S.—are published in the December issue of Catheterization and Cardiovascular Intervention, the official journal of The Society for Cardiovascular Angiography and Interventions.

7 Dec 2010

Stereotaxis awarded VA Federal Supply Schedule Contract for Niobe Remote Magnetic Navigation System

Stereotaxis, Inc. announced that the United States Department of Veteran Affairs awarded Stereotaxis a Federal Supply Schedule Contract for its Niobe® Remote Magnetic Navigation System, related service agreement, and disposable products. This contract, effective December 15, 2010, is for five years, with a five year renewal option.

7 Dec 2010

Rcadia's COR Analyzer System effective to rule-out coronary artery disease

Physicians at Thomas Jefferson University Hospital reported today on results of a study demonstrating the potential for fully automated interpretation of coronary CT angiography (cCTA) by Rcadia's COR Analyzer® System to safely rule out coronary artery disease (CAD) in the major coronary arteries as well as branch vessels.

3 Dec 2010

FDA approves IDE application to initiate Tryton Side Branch Stent System for coronary artery disease

Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced U.S. Food and Drug Administration (FDA) conditional approval for an Investigational Device Exemption (IDE) application to initiate the pivotal trial to evaluate the Tryton Side Branch Stent System for the treatment of coronary artery disease.

2 Dec 2010

Denmark grants marketing authorization for SUMAVEL DosePro Needle-Free Delivery System

Zogenix, Inc. and Desitin Pharmaceuticals GmbH today announced that the Danish Medicines Agency of Denmark has approved the Marketing Authorization Application (MAA) for SUMAVEL® DosePro™ (sumatriptan injection) Needle-Free Delivery System. Denmark is the first country in Europe to grant marketing authorization for SUMAVEL DosePro for the acute treatment of migraine attacks, with or without aura, and the acute treatment of cluster headache.

2 Dec 2010

Nine out of ten of all primary care centers in Sweden prescribe physical activity

Prescribing physical activity for the purpose of preventing and treating various conditions can now become a reality for healthcare professionals all over the world.

30 Nov 2010

Study confirms difference in coronary artery disease pathways among Caucasians, African Americans

In a study being presented today at the annual meeting of the Radiological Society of North America (RSNA), researchers say they may have an explanation as to why African Americans, despite having lower amounts of coronary artery calcification, are at increased risk for heart attacks and other cardiovascular events compared with Caucasians.

30 Nov 2010

Siemens to distribute Rcadia's COR Analyzer System

Rcadia Medical Imaging and Siemens Healthcare have entered into an agreement for Siemens to distribute Rcadia's COR Analyzer® System. The COR Analyzer's ability to identify stenotic lesions in Coronary Computed Tomography Angiography (cCTA) studies in combination with Siemens' Syngo®.via CT Cardio-Vascular Engine provides a comprehensive solution for evaluating suspected cardiac patients. The integration of both systems realizes a seamless workflow with enhanced productivity.

30 Nov 2010

Micell initiates enrollment in DESSOLVE I clinical trial of MiStent DES

Micell Technologies,™ Inc. today announced it has enrolled at Mercy Hospital in Auckland, New Zealand, the first patient in DESSOLVE I (DES with Sirolimus and a bioabsorbable pOLymer for the treatment of patients with de noVo lEsions in the native coronary arteries), a first-in-human clinical trial of the company's investigational MiStent™ Drug Eluting Coronary Stent System (MiStent DES).

29 Nov 2010

Study reports increased CT usage in emergency departments

A new study reports that the use of computed tomography (CT) in the nation's emergency departments is growing exponentially. If the growth trend continues, by 2011, nearly 20 percent of all emergency department (ED) visits may involve a CT exam. The results of this study were presented today at the annual meeting of the Radiological Society of North America (RSNA) and published online and in the journal Radiology.

29 Nov 2010

More salt in many holiday meals, cardiologist warns

There can be far more salt in many holiday meals than people realize, and the proof can be found at hospital emergency rooms. Heart problems aggravated or unmasked after ingestion of a significant amount of salt tend to make holidays such as Thanksgiving, Passover and Christmas very busy times for health providers like University of Medicine and Dentistry of New Jersey (UMDNJ) cardiologist Marc Klapholz, M.D., F.A.C.C.

24 Nov 2010

Cardiac stem cells from sick patients could generate new heart muscle: Research

Cardiac stem cells even in elderly and sick patients could generate new heart muscle and vessel tissue and be used to treat heart failure, according to research presented at the American Heart Association's Scientific Sessions 2010.

18 Nov 2010

NT-proBNP guided heart failure care associated with reduced cardiovascular events

Roche and study investigators from Harvard University and Massachusetts General Hospital announced today that in the PROTECT (Pro-BNP Outpatient Tailored Chronic HF Therapy) trial, a strategy of NT-proBNP guided heart failure care was independently associated with a significant reduction in total cardiovascular events, the primary composite endpoint of the study, which included worsening heart failure, heart failure hospitalization and cardiovascular related death

From Roche Sequencing and Life Science 17 Nov 2010

Anthera places voluntary hold on A-623 Phase 2b study for lupus

Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced that it has notified the US Food and Drug Administration (FDA) that the company has placed a voluntary hold on PEARL-SC, the Phase 2b study of A-623 for the treatment of Systemic Lupus Erythematosus (lupus), due to problems found with product vials.

17 Nov 2010

Combination of CT scans effective in diagnosing coronary artery disease

Heart imaging specialists at Johns Hopkins have shown that a combination of CT scans that measure how much blood is flowing through the heart and the amount of plaque in surrounding arteries are just as good as tests that are less safe, more complex and more time-consuming to detect coronary artery disease and its severity.

17 Nov 2010

TRITON–TIMI 38 substudy shows prasugrel reduces overall mortality rate in ACS patients

New results from an observational substudy from TRITON–TIMI 38 presented today at the American Heart Association (AHA) Scientific Sessions annual meeting showed that patients treated with Efient/Effient (prasugrel) prior to coronary artery bypass graft surgery (CABG) had a reduced overall mortality rate compared to patients treated with Plavix (clopidogrel)

17 Nov 2010

InfraReDx to present LipiScan scientific abstracts at AHA 2010

InfraReDx, Inc., a medical device company developing intelligent cardiovascular diagnostic imaging technologies, today announced the upcoming presentation of three LipiScan-related scientific abstracts at the American Heart Association Scientific Sessions 2010 (AHA 2010), being held Nov. 13-17, 2010 at McCormick Place in Chicago.

15 Nov 2010

Results of RE-LY trial evaluating Pradaxa capsules to be presented at American Heart Association Session

Results of two pre-specified sub-study analyses of the 18,113 patient RE-LY trial, involving the newly approved oral anticoagulant Pradaxa (dabigatran etexilate mesylate) capsules, will be presented at the American Heart Association's Annual Scientific Sessions on Monday, November 15, 2010.

12 Nov 2010

Coronary Artery Disease News and Research

Latest Coronary Artery Disease News and Research

Detection of blood biomarker cTnT associated with structural heart disease

New sensitive blood test could determine unrecognized heart disease

Sheathless transradial intervention highly successful in treating complex lesions

Stereotaxis awarded VA Federal Supply Schedule Contract for Niobe Remote Magnetic Navigation System

Rcadia's COR Analyzer System effective to rule-out coronary artery disease

FDA approves IDE application to initiate Tryton Side Branch Stent System for coronary artery disease

Denmark grants marketing authorization for SUMAVEL DosePro Needle-Free Delivery System

Nine out of ten of all primary care centers in Sweden prescribe physical activity

Study confirms difference in coronary artery disease pathways among Caucasians, African Americans

Siemens to distribute Rcadia's COR Analyzer System

Micell initiates enrollment in DESSOLVE I clinical trial of MiStent DES

Study reports increased CT usage in emergency departments

More salt in many holiday meals, cardiologist warns

Cardiac stem cells from sick patients could generate new heart muscle: Research

NT-proBNP guided heart failure care associated with reduced cardiovascular events

Anthera places voluntary hold on A-623 Phase 2b study for lupus

Combination of CT scans effective in diagnosing coronary artery disease

TRITON–TIMI 38 substudy shows prasugrel reduces overall mortality rate in ACS patients

InfraReDx to present LipiScan scientific abstracts at AHA 2010

Results of RE-LY trial evaluating Pradaxa capsules to be presented at American Heart Association Session

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Coronary Artery Disease News and Research

Latest Coronary Artery Disease News and Research

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in